Treatment of Facial Flushing With Botulinum Toxin A Injections

Running, not enrolling · Phase 4

Conditions studied: Facial Flushing

In brief

The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat facial flushing. This study is a pilot study designed to determine feasibility of these procedures.

Key facts

Study ID

NCT02216838

Run by

Northwestern University

People needed

16

Starts

2014-08-01

Expected to finish

2027-12-01

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients 18-65 years of age with persistent facial flushing
• Willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the study staff.

You may not qualify if…

• Unable to understand the protocol or give informed consent
• Younger than 18 or older than 65 years of age
• Females who are pregnant or lactating
• Known hypersensitivity to BTX-A
• Subjects using medications that interfere with neuromuscular functions (such as aminoglycoside antibiotics)
• Subjects who have a history of congestive heart failure, carcinoid syndrome, mastocystosis, or renal cell carcinoma
• Botulinum toxin injections in the past 6 months
• Ablative laser procedure in the past 6 months
• Radiofrequency device treatment in the past 6 months
• Ultrasound device treatment in the past 6 months
• Medium to deep chemical peel in the past 6 months
• Temporary soft tissue augmentation material in the area to be treated in the past year
• Semi-permanent soft tissue augmentation material in the area to be treated in the past 2 years
• Permanent soft tissue augmentation material in the area to be treated
• Is planning to receive within the next 6 months, any cosmetic procedure (such as any chemical peels, botulinum toxin injections, ablative or non-ablative laser procedures, filler injections, radiofrequency procedures, dermabrasion, ultrasound and face lifting procedures) in the forehead or glabellar region.
• Is planning to use tretinoin or retinoic acid in the next 6 months
• Has an active infection in the forehead or glabellar region (excluding mild acne)
• Is allergic to cow's milk protein
• Is allergic to albumin
• Is currently using anticoagulation therapy
• Has a history of bleeding disorders

Where it is running

• Northwestern University Feinberg School of Medicine, Department of Dermatology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.